BioVU Archive — Page 3 of 8
-
January 10, 2023
Anti-nausea drug response in children
Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report. -
December 19, 2022
Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples
BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples. -
August 25, 2022
New high-tech biobank safeguards critical specimens
-
August 11, 2022
Genotype-specific blood counts
Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts. -
June 29, 2022
Study shows genotype leads to discontinued, decreased medication
-
June 16, 2022
BMI genetics influence heart function
Vanderbilt researchers have discovered that a genetic predisposition to elevated body mass index increases the risk of diastolic dysfunction — a cardiac condition that can lead to heart failure. -
June 8, 2022
BioVU celebrates 15 years supporting personalized medicine
BioVU is celebrating its 15th year and has enabled hundreds of studies and publications exploring the genetic underpinnings of a host of conditions including cancer, heart disease and diabetes.